相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
Samantha L. Goldman et al.
FRONTIERS IN GENETICS (2019)
DNA methyltransferase 1?mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1?driven leukemogenesis
Tianxiang Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization
Eugen Werwein et al.
NUCLEIC ACIDS RESEARCH (2019)
Targeting Transcription Factors for Cancer Treatment
Melanie Lambert et al.
MOLECULES (2018)
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Tiziano Barbui et al.
BLOOD CANCER JOURNAL (2018)
Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations (vol 7, 6774, 2017)
Helene Myrtue Nielsen et al.
SCIENTIFIC REPORTS (2018)
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2017)
The BAF45a/PHF10 subunit of SWI/SNF-like chromatin remodeling complexes is essential for hematopoietic stem cell maintenance
Veneta Krasteva et al.
EXPERIMENTAL HEMATOLOGY (2017)
Epigenetics in Myeloproliferative Neoplasms
Suzanne McPherson et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
A phase II study of panobinostat in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
John Mascarenhas et al.
LEUKEMIA RESEARCH (2017)
YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer
Wenyi Mi et al.
NATURE COMMUNICATIONS (2017)
The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells
Natalia Gawlik-Rzemieniewska et al.
CANCER BIOLOGY & THERAPY (2016)
Novel functions for the transcription factor E2F4 in development and disease
Jenny Hsu et al.
CELL CYCLE (2016)
Mutations in MPNs: prognostic implications, window to biology, and impact on treatment decisions
Jamile M. Shammo et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Dynamic Phosphorylation of CENP-A at Ser68 Orchestrates Its Cell-Cycle-Dependent Deposition at Centromeres
Zhouliang Yu et al.
DEVELOPMENTAL CELL (2015)
StemChecker: a web-based tool to discover and explore stemness signatures in gene sets
Jose P. Pinto et al.
NUCLEIC ACIDS RESEARCH (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: A TRAnsition to targeted therapies
M. F. Arteaga et al.
BRITISH JOURNAL OF CANCER (2015)
Targeting cell cycle regulators in hematologic malignancies
Eiman Aleem et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union
Odile Moulard et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Epidemiology of myeloproliferative neoplasms in the United States
Jyotsna Mehta et al.
LEUKEMIA & LYMPHOMA (2014)
NET23/STING Promotes Chromatin Compaction from the Nuclear Envelope
Poonam Malik et al.
PLOS ONE (2014)
Concise Review: Evidence for CD34 as a Common Marker for Diverse Progenitors
Laura E. Sidney et al.
STEM CELLS (2014)
TET2 Deficiency Inhibits Mesoderm and Hematopoietic Differentiation in Human Embryonic Stem Cells
Thierry Langlois et al.
STEM CELLS (2014)
Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis
Richard T. Silver et al.
BLOOD (2013)
Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
Cigall Kadoch et al.
CELL (2013)
Dynamic Readers for 5-(Hydroxy)Methylcytosine and Its Oxidized Derivatives
Cornelia G. Spruijt et al.
CELL (2013)
Role and potential for therapeutic targeting of MYB in leukemia
D. R. Pattabiraman et al.
LEUKEMIA (2013)
Control of cell cycle transcription during G1 and S phases
Cosetta Bertoli et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
JAK/STAT signaling in hematological malignancies
W. Vainchenker et al.
ONCOGENE (2013)
Establishing a hematopoietic genetic network through locus-specific integration of chromatin regulators
Andrew W. DeVilbiss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Binding of TFIIIC to SINE Elements Controls the Relocation of Activity-Dependent Neuronal Genes to Transcription Factories
Luca Crepaldi et al.
PLOS GENETICS (2013)
Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells
Wai Feng Lim et al.
STEM CELL RESEARCH & THERAPY (2013)
Negative Regulation of JAK2 by H3K9 Methyltransferase G9a in Leukemia
Hye-Ju Son et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F
Rajintha M. Bandaranayake et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Novel Fusion of MYST/Esa1-Associated Factor 6 and PHF1 in Endometrial Stromal Sarcoma
Ioannis Panagopoulos et al.
PLOS ONE (2012)
Phosphorylation of EZH2 by CDK1 and CDK2 A possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions
Xianzhuo Zeng et al.
CELL CYCLE (2011)
LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease
Dean S. Griffiths et al.
NATURE CELL BIOLOGY (2011)
A framework for oligonucleotide microarray preprocessing
Benilton S. Carvalho et al.
BIOINFORMATICS (2010)
A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms
Alessandro Rambaldi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Coordinate regulation of histone mRNA metabolism and DNA replication Cyclin A/cdk1 is involved in inactivation of histone mRNA metabolism and DNA replication at the end of S phase
M. Murat Koseoglu et al.
CELL CYCLE (2010)
Transcription factor co-repressors in cancer biology: roles and targeting
Sebastiano Battaglia et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
LEUKEMIA (2010)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Smarcc1/Baf155 Couples Self-Renewal Gene Repression with Changes in Chromatin Structure in Mouse Embryonic Stem Cells
Christoph Schaniel et al.
STEM CELLS (2009)
The history of myeloproliferative disorders: before and after Dameshek
A. Tefferi
LEUKEMIA (2008)
Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome - Comparison with historical experience
Hagop M. Kantarjian et al.
CANCER (2007)
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis
Linda M. Scott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B
Lewis R. Silverman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus
K. M. Viiri et al.
NUCLEIC ACIDS RESEARCH (2006)
Core transcriptional regulatory circuitry in human embryonic stem cells
LA Boyer et al.
CELL (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
The XRCC genes:: expanding roles in DNA double-strand break repair
J Thacker et al.
DNA REPAIR (2004)
The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function
M Monte et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability
AHFM Peters et al.
CELL (2001)
Different kinases phosphorylate nucleophosmin/B23 at different sites during G2 and M phases of the cell cycle
PS Jiang et al.
CANCER LETTERS (2000)
Regulation of the Jak2 tyrosine kinase by its pseudokinase domain
P Saharinen et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)